^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TYRA-300

    i
    Other names: TYRA-300
    Company:
    Tyra Biosci
    Drug class:
    FGFR3 inhibitor
    Related drugs:
    2ms
    A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants (clinicaltrials.gov)
    P1, N=60, Recruiting, Tyra Biosciences, Inc | N=36 --> 60 | Trial primary completion date: Jan 2024 --> May 2024
    Enrollment change • Trial primary completion date
    |
    TYRA-300
    5ms
    A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants (clinicaltrials.gov)
    P1, N=36, Recruiting, Tyra Biosciences, Inc
    Trial completion date • Trial primary completion date
    |
    TYRA-300
    6ms
    A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants (clinicaltrials.gov)
    P1, N=36, Recruiting, Tyra Biosciences, Inc | Not yet recruiting --> Recruiting
    Enrollment open
    |
    TYRA-300